Product Information
ICOSAPENT ETHYL 0.5 GM CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3342 per EA under NDC 00054062127. Its NADAC has been published 159 times since Sep 20, 2023.
FDA first approved this application on May 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 g/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054062127
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ICOSAPENT ETHYLApproval Type
Generic (ANDA)
FDA Application
ANDA209457FDA Approved
5/21/2020
TE Code
AB
On Market Since
11/4/2020
Price Statistics
The NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has been published 159 times since Sep 20, 2023, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3342 per EA |
|---|---|
| All-time high | $1.0599 (Apr 10, 2024) |
| All-time low | $0.3208 (Feb 18, 2026) |
| 52-week high | $0.5623 |
| 52-week low | $0.3208 |
| Median price | $0.5953 |
| Average price | $0.6413 |
| Largest weekly change | -24.1% (Nov 20, 2024) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Icosapent Ethyl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Icosapent Ethyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ICOSAPENT ETHYL 0.5 GM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ICOSAPENT ETHYL 0.5 GM CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3342 per EA (NDC 00054062127), effective Sep 30, 2026.
How has the price of ICOSAPENT ETHYL 0.5 GM CAPSULE changed over time?
Over the history we have for it, the NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has declined 68.5%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for ICOSAPENT ETHYL 0.5 GM CAPSULE?
Since Sep 20, 2023, the NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has ranged from a low of $0.3208 (Feb 18, 2026) to a high of $1.0599 (Apr 10, 2024), with a median of $0.5953 per EA.
Are there cheaper alternatives to ICOSAPENT ETHYL 0.5 GM CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ICOSAPENT ETHYL 0.5 GM CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ICOSAPENT ETHYL 0.5 GM CAPSULE?
ICOSAPENT ETHYL 0.5 GM CAPSULE (NDC 00054062127) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.